Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexandru P. Ivan"'
Autor:
Hugh S. Gannon, Tao Zou, Michael K. Kiessling, Galen F. Gao, Diana Cai, Peter S. Choi, Alexandru P. Ivan, Ilana Buchumenski, Ashton C. Berger, Jonathan T. Goldstein, Andrew D. Cherniack, Francisca Vazquez, Aviad Tsherniak, Erez Y. Levanon, William C. Hahn, Matthew Meyerson
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/7f389bc2de07430a8b35aca7b771b3bf
Autor:
Hugh S. Gannon, Tao Zou, Michael K. Kiessling, Galen F. Gao, Diana Cai, Peter S. Choi, Alexandru P. Ivan, Ilana Buchumenski, Ashton C. Berger, Jonathan T. Goldstein, Andrew D. Cherniack, Francisca Vazquez, Aviad Tsherniak, Erez Y. Levanon, William C. Hahn, Matthew Meyerson
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Specific cancer cell vulnerabilities can provide an opportunity for the development of novel cancer therapeutics. In this study the authors demonstrate that targeting ADAR1 represents a potential therapeutic vulnerability in cancers with activated in
Externí odkaz:
https://doaj.org/article/101c1efd608349f2b4bd50157c1c3989
Autor:
Aviad Tsherniak, Andrew D. Cherniack, Francisca Vazquez, Erez Y. Levanon, William C. Hahn, Matthew Meyerson, Michael K. Kiessling, Tao Zou, Alexandru P. Ivan, Diana Cai, Ilana Buchumenski, Galen F. Gao, Hugh S. Gannon, Ashton C. Berger, Jonathan T. Goldstein, Peter S. Choi
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications
Nature Communications
Systematic exploration of cancer cell vulnerabilities can inform the development of novel cancer therapeutics. Here, through analysis of genome-scale loss-of-function datasets, we identify adenosine deaminase acting on RNA (ADAR or ADAR1) as an essen